Artificially sweetened beverages and urinary incontinence—a secondary analysis of the Women's Health Initiative Observational Study
Ringel N, Hovey K, Andrews C, Mossavar-Rahmani Y, Shadyab A, Snetselaar L, Howard B, Iglesia C. Artificially sweetened beverages and urinary incontinence—a secondary analysis of the Women's Health Initiative Observational Study. Menopause The Journal Of The North American Menopause Society 2022, 30: 283-288. PMID: 36515559, PMCID: PMC9974739, DOI: 10.1097/gme.0000000000002129.Peer-Reviewed Original ResearchMeSH KeywordsArtificially Sweetened BeveragesFemaleHumansRisk FactorsSweetening AgentsUrinary IncontinenceWomen's HealthConceptsUrinary incontinence symptomsWomen's Health Initiative Observational StudyUrgency urinary incontinence symptomsMixed urinary incontinenceUrinary incontinenceIncontinence symptomsObservational studyBeverage consumptionSecondary analysisMultivariable logistic regression modelLogistic regression modelsAnalytic cohortMultivariable analysisPotential confoundersUnadjusted oddsBeverage intakeHigh prevalenceHigher oddsIncontinenceGreater oddsRare consumersSymptomsWeeksDemographic characteristicsWomenPostprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of onabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial
Chang E, Ringel N, Woodburn K, Tanner J, Bassaly R, Greene K, Wyman A, Iglesia C. Postprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of onabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial. Urogynecology 2022, 28: 518-525. PMID: 35543540, DOI: 10.1097/spv.0000000000001199.Peer-Reviewed Original ResearchMeSH KeywordsBotulinum Toxins, Type AHumansInjections, IntramuscularPain, ProceduralTreatment OutcomeUrinary Bladder, OveractiveUrinary IncontinenceConceptsUrgency urinary incontinenceOveractive bladderProcedure timeIntradetrusor injectionsAdverse eventsUrinary incontinenceClinical trialsSubjective efficacyAverage pain scoreGlobal response assessmentRefractory overactive bladderIdiopathic overactive bladderVisual analog scalePain scoresOnabotulinumtoxinA treatmentPain AssociatedPain levelsWeeks postprocedurePostprocedure complicationsAnalog scaleProcedure durationResponse assessmentPatient experiencePatientsInjection paradigmPostoperative Urinary Incontinence in Diabetic Patients Undergoing Pelvic Reconstructive Surgery
Siddique M, Ringel N, de Winter K, Marczak T, Kisby C, Rutledge E, Soriano A, Samimi P, Schroeder M, Handler S, Chou J, Gutman R. Postoperative Urinary Incontinence in Diabetic Patients Undergoing Pelvic Reconstructive Surgery. Urogynecology 2022, 28: 372-378. PMID: 35113049, DOI: 10.1097/spv.0000000000001137.Peer-Reviewed Original ResearchConceptsStress urinary incontinencePelvic organ prolapsePelvic reconstructive surgeryUrgency urinary incontinencePostoperative urinary incontinenceAnti-incontinence surgeryUrinary incontinenceReconstructive surgeryDe novo urgency urinary incontinenceMulticenter retrospective cohort studyPostoperative stress urinary incontinencePersistent stress urinary incontinenceMixed urinary incontinenceRetrospective cohort studyHemoglobin A1c levelsIndependent risk factorCohort of womenDiverse medical centersPostoperative incontinenceSUI surgeryCohort studyIncontinence proceduresA1c levelsDiabetes mellitusDiabetic patients